Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for MediWound (MDWD) over the last 13 years, with Q3 2025 value amounting to $3.7 million.

  • MediWound's Other Accumulated Expenses rose 3918.92% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 3918.92%. This contributed to the annual value of $3.6 million for FY2024, which is 860.96% down from last year.
  • Latest data reveals that MediWound reported Other Accumulated Expenses of $3.7 million as of Q3 2025, which was up 3918.92% from $3.4 million recorded in Q2 2025.
  • In the past 5 years, MediWound's Other Accumulated Expenses ranged from a high of $5.2 million in Q1 2021 and a low of $2.7 million during Q3 2024
  • Moreover, its 5-year median value for Other Accumulated Expenses was $3.5 million (2024), whereas its average is $3.6 million.
  • As far as peak fluctuations go, MediWound's Other Accumulated Expenses plummeted by 4093.19% in 2022, and later skyrocketed by 3918.92% in 2025.
  • Quarter analysis of 5 years shows MediWound's Other Accumulated Expenses stood at $3.6 million in 2021, then increased by 14.89% to $4.2 million in 2022, then decreased by 6.44% to $3.9 million in 2023, then fell by 8.61% to $3.6 million in 2024, then rose by 4.27% to $3.7 million in 2025.
  • Its Other Accumulated Expenses was $3.7 million in Q3 2025, compared to $3.4 million in Q2 2025 and $3.3 million in Q1 2025.